Skip to main content

Articles

Page 17 of 17

  10. The peritoneum is the largest and most complexly arranged serous membrane in the body. The potential peritoneal spaces, the peritoneal reflections forming peritoneal ligaments, mesenteries, omenta, and the nat...

    Authors: Jeremiah C. Healy
    Citation: Cancer Imaging 2015 1:10286
    Content type: Review Published on:

  11. In patients with liver cirrhosis, arterial phase enhancement of nodular lesions on helical-CT is currently considered to be highly predictive of malignancy. We report the spontaneous regression of a hypervascu...

    Authors: Alain Luciani, Alain Rahmouni, Hamid Achab, Didier Mathieu, Nedal Jazaerli and Mohamed Bouanane
    Citation: Cancer Imaging 2015 1:10279
    Content type: Case Report Published on:

  15. It is important to distinguish liver metastases from incidental benign liver lesions which may be present in patients with cancer. In a minority of cases, sonography or CT may be sufficient to characterise ben...

    Authors: P. J. Robinson
    Citation: Cancer Imaging 2015 2:17
    Content type: Review Published on:

  17. Multiple myeloma is characterised by a progressive proliferation of malignant plasma cells usually initiating in the bone marrow. The most common manifestations of this disease are bone involvement, renal dise...

    Authors: Michael Patlas, Irith Hadas-Halpern and Eugene Libson
    Citation: Cancer Imaging 2015 2:15
    Content type: Review Published on:

  19. In 1923 Masson described a neo-plastic process consisting of papillary hyperplasia of the vascular endothelial cells, with a consequent obliteration of the vascular lumen, followed by degenerative changes. He ...

    Authors: S. Van den Bogaert, K. Boel, H. Van Poppel, R. Oyen and B. Van Damme
    Citation: Cancer Imaging 2015 2:14
    Content type: Case Report Published on:

  30. In the management of patients with lymphoma, imaging is essential not only for diagnosis but also to define prognosis and treatment by staging. Imaging is also used to assess the response to treatment that may...

    Authors: A. Rahmouni, M. Divine, S. Kriaa, C. Haïoun, M.-C. Anglade and H. Kobeiter
    Citation: Cancer Imaging 2015 2:7
    Content type: Review Published on:

  32. Authors: R. C. G. Russell
    Citation: Cancer Imaging 2015 2:5
    Content type: Multidisciplinary Symposium — Carcinoma of the Pancreas: Monday 15 October 2001, 15.30–Close Published on:

  33. The ability to demonstrate tumour foci that are undetected by conventional imaging has resulted in the emergence of positron emission tomography (PET) as a valuable clinical tool in oncology. This article desc...

    Authors: K. A. Miles
    Citation: Cancer Imaging 2015 2:5
    Content type: Review Published on:

  34. Authors: B. Rufford, U. Menon and I. Jacobs
    Citation: Cancer Imaging 2015 2:4
    Content type: Multidisciplinary Symposium — Screening for Cancer: Monday 15 October 2001, 10.20–12.45 Published on:

  35. Nuclear medicine techniques designed to identify bone metastases are reviewed. They include planar and whole body, single photon emission tomography (SPET), F-18 Fluorine and FDG, deoxyglucose, positron emissi...

    Authors: K. E. Britton
    Citation: Cancer Imaging 2015 2:4
    Content type: Review Published on:

  36. Authors: Jay P. Heiken
    Citation: Cancer Imaging 2015 2:3
    Content type: Multidisciplinary Symposium — Screening for Cancer: Monday 15 October 2001, 10.20–12.45 Published on:

  37. There is no set protocol for imaging prostate cancer, and a selection of a particular modality (TRUS, CT or MRI) often depends on the equipment and local expertise available. None of the imaging modality is pe...

    Authors: Hedvig Hricak
    Citation: Cancer Imaging 2015 2:3
    Content type: Review Published on:

Official journal of

Follow

Annual Journal Metrics

Download journal leaflet

Cancer Imaging

ISSN: 1470-7330

Contact us